1. Home
  2. ACLS vs FOLD Comparison

ACLS vs FOLD Comparison

Compare ACLS & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axcelis Technologies Inc.

ACLS

Axcelis Technologies Inc.

HOLD

Current Price

$166.66

Market Cap

5.0B

Sector

Technology

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.49

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACLS
FOLD
Founded
1995
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.5B
IPO Year
2000
2006

Fundamental Metrics

Financial Performance
Metric
ACLS
FOLD
Price
$166.66
$14.49
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$101.50
$27.25
AVG Volume (30 Days)
785.7K
2.7M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
0.30
N/A
Revenue
$839,048,000.00
N/A
Revenue This Year
$1.93
$20.50
Revenue Next Year
$7.91
$18.59
P/E Ratio
$42.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$55.96
$5.66
52 Week High
$171.61
$14.50

Technical Indicators

Market Signals
Indicator
ACLS
FOLD
Relative Strength Index (RSI) 74.29 74.18
Support Level $77.19 $14.21
Resistance Level N/A N/A
Average True Range (ATR) 8.30 0.02
MACD 1.97 -0.00
Stochastic Oscillator 89.42 100.00

Price Performance

Historical Comparison
ACLS
FOLD

About ACLS Axcelis Technologies Inc.

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips. In addition to equipment, the company provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. Geographically, the group has a business presence in North America, Asia Pacific, and Europe, of which key revenue is derived from the Asia Pacific.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: